Silicon Canals
No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us
No Result
View All Result
Silicon Canals
No Result
View All Result

Peter Thiel backs German startup that develops psychedelic therapy for mental health disorders; firm secures €105M

Editorial team by Editorial team
November 27, 2020
in (Crowd)funding, Health & Medtech, News, Startups
Mental Health
96
SHARES
LinkedInTwitterWhatsAppFacebook
Read this article in:

The coronavirus pandemic has sent a shockwave across the world, taking an unprecedented toll on our lives including mental health since the majority of us are confined to work and exercise from home. 

According to a report by WHO Euro (World Health Organisation Europe), in many western countries, mental health disorders are the major cause of disability, accounting for 30% to 40% of chronic sick leaves, and costing nearly 3% of GDP. 

Also, the Health at a Glance: Europe report states that mental health issues such as anxiety, depression, and drug use disorders affect over one in six people across the European Union. Embracing the opportunity, many startups have started using various technological advancements to improve mental healthcare. 

In this regard, Berlin-based ATAI Life Sciences is a biotech platform founded in response to the clear and growing unmet needs of mental health patients worldwide. In the latest development, the German company announced a $125M (approx €105M) funding in the Series C financing round, including $32M (approx €27M) of its 2020 convertible debt that converted in connection with the Series C.

- Partner content -
Atlas HXM EOR Employee of Record
How EOR is becoming a crucial tool in 2023
EOR gains importance as companies digitise and hire globally. Learn from industry leaders...Show More
EOR gains importance as companies digitise and hire globally. Learn from industry leaders using EOR with Atlas HXM.Show Less
Read more

Who led the funding round?

The round was co-led by Apeiron Investment Group, the family office of ATAI’s founder Christian Angermayer, Peter Thiel, and Catalio Capital Management. Other existing investors – Future Ventures and Galaxy Investment Partners, as well as new investors – Falcon Edge Capital and Pura Vida Pro, LLC – also participated in the round. 

How will the funding be used?

The German startup will use the proceeds to fund pre-clinical and clinical development of ATAI’s existing mental health programs, to expand its drug candidate pipeline, and further advance ATAI’s platform technologies. 

According to the company, this funding will provide the necessary runway to accomplish several key clinical milestones including Phase 2 data readouts for arketamine in treatment-resistant depression at Perception Neuroscience and ibogaine in opioid use disorder at DemeRx. Also, the financing will be used in the completion of Phase 1 and the initiation of Phase 2 trials at four other programs.

Treating mental health

Founded by Christian Angermayer, Florian Brand, and Lars Christian Wilde in 2018, ATAI is dedicated to acquiring, incubating, and efficiently developing therapeutics to treat depression, anxiety, addiction, and other mental health disorders. The company’s business model focus on psychedelic therapy and other drugs with differentiated safety profiles and therapeutic potential.

Florian Brand, CEO & co-founder of ATAI Life Sciences, says, “We believe that our psychedelic and non-psychedelic compounds have compelling therapeutic promise based upon a growing body of scientific evidence.”

Headquartered in Berlin, with offices in New York and San Diego. To date, the company has raised $232.1M (approx €195M) in funding with backing from various investors.

Main image credits: ATAI Life Sciences

 - Partner content -
How to succesfully outsource…
How to succesfully outsource…
...your recruitment or product development with our curated community partners!
...your recruitment or product development with our curated community partners! Show Less
Read more
Tags: fundingGerman startupshealthtech
Share7Tweet24SendShare38

Partner with us | Download Media Kit

Thank you for visiting Silicon Canals! If you want to partner with us, look at our options.

Featured | Tech Events

Current Month

september, 2023

Silicon Canals | Jobs

Breaking news from Amsterdam | Partner

Endeit Capital backs Amsterdam’s Lepaya in €35M round to revolutionise corporate learning through AI

Chemical Utopia: How Amsterdam Chemistry Network’s ChemAI aims to upend Dutch Chemistry

Amsterdam’s Truvity launches Truvity Platform to revolutionise digital identity verification technology

Partner content | Work with us

Amsterdam’s Invest-NL takes center stage in protecting Dutch companies from unwanted takeovers: Here’s how

[Exclusive] Amsterdam’s YourKitchen gets acquired by The Kitchen Dojo and Trias Real Estate: Know more

Meet Samaa Mohammad, an AI ethicist solving diversity problem with Techleap.nl’s DLiT Community

  • About Silicon Canals
  • Partner with Silicon Canals
  • Impressum
  • Contact us
  • Sign up for our newsletter!
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

X
X